These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24520068)

  • 1. Antibody-based proteomics and biomarker research - current status and limitations.
    Solier C; Langen H
    Proteomics; 2014 Mar; 14(6):774-83. PubMed ID: 24520068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H; Schanstra JP
    Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-content affinity-based proteomics: unlocking protein biomarker discovery.
    Brody EN; Gold L; Lawn RM; Walker JJ; Zichi D
    Expert Rev Mol Diagn; 2010 Nov; 10(8):1013-22. PubMed ID: 21080818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data processing pipelines for comprehensive profiling of proteomics samples by label-free LC-MS for biomarker discovery.
    Christin C; Bischoff R; Horvatovich P
    Talanta; 2011 Jan; 83(4):1209-24. PubMed ID: 21215856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why have so few proteomic biomarkers "survived" validation? (Sample size and independent validation considerations).
    Hernández B; Parnell A; Pennington SR
    Proteomics; 2014 Jul; 14(13-14):1587-92. PubMed ID: 24737731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in proximal fluid proteomics for disease biomarker discovery.
    Teng PN; Bateman NW; Hood BL; Conrads TP
    J Proteome Res; 2010 Dec; 9(12):6091-100. PubMed ID: 21028795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted proteomics strategy applied to biomarker evaluation.
    Kim YJ; Gallien S; van Oostrum J; Domon B
    Proteomics Clin Appl; 2013 Dec; 7(11-12):739-47. PubMed ID: 24123942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
    Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
    Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity proteomics: the role of specific binding reagents in human proteome analysis.
    Stoevesandt O; Taussig MJ
    Expert Rev Proteomics; 2012 Aug; 9(4):401-14. PubMed ID: 22967077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
    Ahmed FE
    J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alignment of LC-MS images, with applications to biomarker discovery and protein identification.
    Vandenbogaert M; Li-Thiao-Té S; Kaltenbach HM; Zhang R; Aittokallio T; Schwikowski B
    Proteomics; 2008 Feb; 8(4):650-72. PubMed ID: 18297649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry-based biomarker discovery.
    Zhou W; Petricoin EF; Longo C
    Methods Mol Biol; 2012; 823():251-64. PubMed ID: 22081350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
    Fang X; Balgley BM; Lee CS
    Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iTRAQ-labeling for biomarker discovery.
    Desouza LV; Voisin SN; Siu KW
    Methods Mol Biol; 2013; 1002():105-14. PubMed ID: 23625398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic antibody and antigen-based proteomic profiling with microarrays.
    Ayoglu B; Häggmark A; Neiman M; Igel U; Uhlén M; Schwenk JM; Nilsson P
    Expert Rev Mol Diagn; 2011 Mar; 11(2):219-34. PubMed ID: 21405972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S; Kislinger T
    Mol Biosyst; 2011 Feb; 7(2):292-303. PubMed ID: 20976349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein mass spectra data analysis for clinical biomarker discovery: a global review.
    Roy P; Truntzer C; Maucort-Boulch D; Jouve T; Molinari N
    Brief Bioinform; 2011 Mar; 12(2):176-86. PubMed ID: 20534688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.